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Abstract
Background: Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality world-wide. 
The risk for developing preeclampsia varies depending on the underlying mechanism. Because the disorder is 
heterogeneous, the pathogenesis can differ in women with various risk factors. Understanding these mechanisms of 
disease responsible for preeclampsia as well as risk assessment is still a major challenge. The aim of this study was to 
determine the risk factors associated with preeclampsia, in healthy women in maternity hospitals of Karachi and 
Rawalpindi.
Methods: We conducted a hospital based matched case-control study to assess the factors associated with 
preeclampsia in Karachi and Rawalpindi, from January 2006 to December 2007. 131 hospital-reported cases of PE and 
262 controls without history of preeclampsia were enrolled within 3 days of delivery. Cases and controls were matched 
on the hospital, day of delivery and parity. Potential risk factors for preeclampsia were ascertained during in-person 
postpartum interviews using a structured questionnaire and by medical record abstraction. Conditional logistic 
regression was used to estimate matched odds ratios (ORs) and 95% confidence intervals (95% CIs).
Results: In multivariate analysis, women having a family history of hypertension (adjusted OR 2.06, 95% CI; 1.27-3.35), 
gestational diabetes (adjusted OR 6.57, 95% CI; 1.94 -22.25), pre-gestational diabetes (adjusted OR 7.36, 95% CI; 1.37-
33.66) and mental stress during pregnancy (adjusted OR 1.32; 95% CI; 1.19-1.46, for each 5 unit increase in Perceived 
stress scale score) were at increased risk of preeclampsia. However, high body mass index, maternal age, urinary tract 
infection, use of condoms prior to index pregnancy and sociodemographic factors were not associated with higher risk 
of having preeclampsia.
Conclusions: Development of preeclampsia was associated with gestational diabetes, pregestational diabetes, family 
history of hypertension and mental stress during pregnancy. These factors can be used as a screening tool for 
preeclampsia prediction. Identification of the above mentioned predictors would enhance the ability to diagnose and 
monitor women likely to develop preeclampsia before the onset of disease for timely interventions and better 
maternal and fetal outcomes.
Background
Preeclampsia (PE) is a pregnancy-specific condition and
is associated with high maternal mortality and morbidity
as well as risk of perinatal death, preterm birth, and intra-
uterine growth restriction[1]. It occurs in 4 to 7 per cent
of pregnant women worldwide [2]. The etiology of preec-
lampsia remains unclear despite extensive research. Risk
factors for preeclampsia include nulliparity, a family or
own history of PE, pre-existing diabetes or increased
body mass index, multiple pregnancy, maternal age, renal
disease, hypertension or raised blood pressure at booking
and chronic autoimmune disease [3]. The rate of preec-
lampsia has increased worldwide especially in developed
countries by 40% between 1990 and 1999 due to an
increase in number of older mothers and multiple births,
conditions known to increase its risk[4].
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Maternal Mortality is extremely high in Pakistan where
1 in 89 women dies of maternal causes with preeclampsia
and eclampsia as one of the major causes [5]. As preec-
lampsia remains a serious and poorly understood compli-
cation of pregnancy, we need to identify epidemiological
and clinical risk factors to predict it before it threatens
the survival of both mother and fetus. The study of risk
factors and the underlying evidence base can be used to
assess risk of preeclampsia at antenatal booking [6].
There is paucity in studies on preeclampsia and its associ-
ated factors in Pakistan; an economically developing
country in Asia.
This study was conducted to determine factors associ-
ated with PE, in healthy women with single pregnancy in
maternity hospitals of Karachi and Rawalpindi. Moreover,
this study investigated the association between family
history of hypertension and preeclampsia.
Methods
This matched case control study was conducted between
January 2006-December 2007 in six selected maternity
hospitals in Karachi and two maternity hospitals in
Rawalpindi: Aga Khan University Hospital, Sohbraj
Maternity Hospital, Aga Khan Maternity hospital for
women, Karimabad, Aga Khan Maternity hospital for
Women & Children, Garden, Lady Dufferin Hospital and
Jinnah Postgraduate Medical Centre Hospital in Karachi,
and Combined Military Hospital and Military Hospital in
Rawalpindi.
All pregnant women of any age delivering in any of the
above-mentioned hospitals were potential study subjects.
We excluded women with past histories of chronic hyper-
tension, and multiple gestations in current pregnancies.
A case was defined as a woman who had given birth
during the preceding three days and who, in the ante-
natal period or before going into labor, was diagnosed by
an obstetrician as being preeclamptic. Preeclampsia was
defined as pregnancy-induced hypertension associated
with proteinuria. Pregnancy-induced hypertension was
defined as new hypertension with blood pressure of 140
mm Hg systolic or diastolic B.P of 90 mm Hg diastolic or
greater arising after 20 weeks of gestation in a woman
who was normotensive before 20 weeks gestation. Protei-
nuria was defined as excretion of 300 mg or more of pro-
tein in 24 hour urine sample or 1+ or more on dipstick
(ICD-9 codes 642E-Fand ICD -10 code O15).
A control was defined as a woman who gave birth dur-
ing the preceding 3 days and who did not have a diagnosis
of preeclampsia. For each case we interviewed two con-
trols who delivered on the same day in the same hospital
matched on parity. In total 131 cases and 232 controls
were interviewed. The hospital's register was surveyed
each day by the study team members to identify all preec-
lamptic cases, and potential controls. Prior to the inter-
view, informed consent was obtained from all study
participants. Women with preexisting chronic hyperten-
sion, defined as BP greater than 140/90 mmHg before
pregnancy or before 20 weeks' gestation, were excluded.
The data collection was conducted on the post delivery
ward by the specialized doctors using a structured ques-
tionnaire. Women with singleton gestations delivered
after 20 weeks were eligible for inclusion. They were
interviewed at enrollment and within 3 days of delivery.
The questionnaire included information regarding socio-
demographic characteristics, antenatal history and family
history of hypertension and diabetes apart from other
covariates.
Potential risk factors were selected on the basis of liter-
ature review and biological plausibility for an association
with both the exposure and outcome. The covariates
included in the analysis were maternal age, maternal
smoking, gestational diabetes, diabetes mellitus, stress
measured by Perceived Stress Score PSS, sociodemo-
graphic status, age at menarche, body mass index, urine
tract infections, past history of PE, family history of
hypertension, diabetes mellitus, use of condoms, age of
husband, sex of the baby, blood group and RH factor. Dia-
betes mellitus and gestational diabetes were self reported
by the participants and verified by the medical records.
Perceived Stress Scale (PSS) used was a 10-item measure
of stressful situations during the past month [7]. Items are
scored on a five-point scale from 0 to 4; the total score
provides a global measurement of the extent to which an
individual feels overwhelmed. Total scores range from 0
to 40; higher scores indicate greater perceived stress. As
we don't have the data on incidence or prevalence of PE in
Pakistan therefore the prevalence of various risk factors
for pre-eclampsia was ascertained through literature
search. In the sample size calculation, we assumed the
prevalence of the various risk factors amongst the control
group to be in the range of 11-72%. The prevalence of
Diabetes in Pakistan is 11%. With low prevalence of dis-
ease as well as time and financial constraints, we took the
option of taking a 1:2 ratio between cases and controls to
increase the power of the study. Thence in order to be
able to detect an odds ratio of at least 2 with a power of
80%, at a significance level of 5%, we calculated a sample
size of 187 cases and 374 controls. {NCSS statistical soft-
ware & power analysis sample size PASS}.
All data analyses were performed using SAS, version
9.1, for windows (SAS Institute Inc. North Carolina) and
SPSS 16. To identify the factors associated with PE, uni-
variate matched analysis was done by comparing the
cases and controls (1 case: 2 controls) for each variable of
interest and crude matched odds ratio and their 95% con-
fidence intervals along with p values were calculated. In
multivariable analysis, matched analysis in logistic
regression was performed to identify associated factors ofShamsi et al. BMC Women's Health 2010, 10:14
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PE while adjusting for other variables. Finally any variable
with p-value > 0.05, not a confounder or interacting with
other variables were removed from the model to obtain a
parsimonious and biologically meaningful model that
best explains the phenomena of PE.
The study was approved by the Ethical Review Board of
Aga Khan University Hospital.
Results
The sociodemographic, obstetric and antenatal charac-
teristics of all participants are presented in table 1. The
actual sample size achieved was a total of 131 cases
matched on parity, day of delivery and hospital with 262
controls participated in the study of preeclampsia risk
factors. There were 194 nulliparous women and 199
parous women with single pregnancy. No significant dif-
ferences were observed between cases and controls with
regard to maternal age, age at menarche, maternal educa-
tion, socioeconomic status measured by ownership of
house, number of rooms in household, number of house-
hold members, husband's occupation.
Gestational diabetes was higher among cases (12.4%) as
compared to controls (1.9%). Urine tract infections dur-
ing pregnancy were higher among cases compared to
controls (31% among cases and 18.5% among controls).
Pregestational diabetes was higher among cases (5.6%)
compared to controls (0.8%). Family history of diabetes
among first relatives was 43.8% among cases and 29.6%
among controls. Family history of hypertension among
cases was 58.9% as compared to 38.5% among controls.
Mean Perceived stress score was 22 among cases as com-
pared to 20 among controls. The mean prepregnancy
weight for cases was 57.3 kg and for controls it was 55
kgs. There were no differences among cases and controls
with regard to age of husbands, condom use around con-
ception, sex of baby, maternal height, BMI, Blood group
and Rh factor.
Referring to table 2, the significant variables in the final
model were history of gestational diabetes, pregestational
diabetes mellitus, family history of hypertension and per-
ceived stress score. After adjusting for the effect of other
variables in the model it was found that gestational diabe-
tes was independently associated with preeclampsia.
Women with gestational diabetes were at greater odds of
having preeclampsia as compared to those who had no
gestational diabetes (OR = 6.57, CI; 1.94-22.25).
Similarly history of pre-gestational diabetes was inde-
pendently associated with preeclampsia. Women with a
history of pre-gestational diabetes were at greater odds of
having preeclampsia as compared to women without pre-
gestational diabetes (OR = 7.36, CI; 1.37-33.66).
Our study showed that the family history of hyperten-
sion was an important risk factor for preeclampsia. Cases
were 2.3 times more likely to have a positive family his-
tory of hypertension as compared to controls, while keep-
ing no family history of hypertension as the reference
category (OR = 2.06, CI; 1.27-3.35).
Mental stress during pregnancy, measured by Perceived
Stress Scale, was also associated with increased risk of PE
(OR = 1.32; CI; 1.19-1.46). For each 5 unit increase in the
stress score the risk of preeclampsia increased by 1.32.
There was no collinearity between variables included in
the final model.
Discussion
This is the first report of a hospital based case control
study to determine preeclampsia risk factors among
women in Karachi and Rawalpindi. Participants provided
information on all the potential risk factors during post-
partum interviews.
Our results showed that gestational diabetes mellitus
(GDM) was associated with the subsequent development
of preeclampsia. The result of our study showing a rela-
tionship between preeclampsia and diabetes is also con-
sistent with previous findings [6,8-13]. Gestational
diabetes is independently and significantly associated
with an increased risk of preeclampsia and an even minor
degree of glucose intolerance is associated with preec-
lampsia [14-16]. Similarly there was a positive association
between pregestational diabetes and preeclampsia risk.
This finding is also consistently seen in previous studies
[15,17-20]. This association is based on a small number of
cases and control subjects and the confidence interval is
wide.
The findings from our study are biologically plausible
for reason that epidemiological and clinical data docu-
ment a close association between insulin resistance, type
2 diabetes, and hypertension. Hyperinsulinemia has been
shown to stimulate the proliferation of vascular smooth
muscle cells, enhance acute sympathetic nervous system
activity and modify transmembrane cation transport, as
well as renal sodium retention and associated endothelial
dysfunction. All of these alterations may contribute to
blood pressure elevations [21,22].
Our observation of a positive association between fam-
ily history of chronic hypertension and risk of preeclamp-
sia is consistent with several previous reports [23-25].
These studies reported an increase in risk of preeclamp-
sia with positive family history of chronic hypertension.
Our results suggest that family history of hypertension
reflects genetic and behavioral factors whereby women
may be predisposed to an increased preeclampsia risk.
Family history of chronic hypertension is a proxy mea-
sure for hereditary factors as well as common environ-
mental or behavioral exposures that may underlie
preeclampsia risk [26,27]. To the best of our knowledge,
this is the first analysis in Pakistan to assess the effects ofShamsi et al. BMC Women's Health 2010, 10:14
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Table 1: Table showing demographic, socio-economic and obstetrical characteristics of cases and controls with 
preeclampsia (PE) among women in maternity hospitals of Karachi and Rawalpindi (January 2006-December 2007)
Variables Cases (131)
n (%)
Controls (262)
n (%)
P-value
Parity
Nulliparous women 64 (48.9) 130 (49.6) 0.915
Parous women 67 (51.1) 132 (50.4)
Mean maternal age (years)
≤ 18 5 (3.8) 12 (4.6) 0.935
19-34 114 (87.0) 226 (86.6)
≥ 35 12 (9.2) 23 (8.8)
Age at menarche 13.0 ± 1.2 13.0 ± 1.3 0.476
Maternal Smoking 5 (3.8) 16 (6.1) 0.42
Maternal education
Less than 8 years 41 (31.3) 69 (27.2) 0.696
8-12years 64 (48.9) 131 (51.6)
More than 12 years 26 (19.8) 54 (21.3)
Ownership Status
Owned 91 (69.5) 160 (61.1) 0.102
Rented 40 (30.5) 102 (38.9)
Number of rooms in 
household
≤ 3 73 (55.7) 145 (55.3) 0.943
> 3 58 (44.3) 117 (44.7)
Mean number of household 
members
≤ 6 63 (48.1) 147 (56.1) 0.133
>6 68 (51.9) 115 (43.9)
Husband's occupation
Private job 42 (32.1) 98 (37.4) 0.296
Government job 50 (38.2) 108 (41.2)
Business 29 (22.1) 44 (16.8)
Others 10 (7.6) 12 (4.6)
Monthly household income
>10000 45 (34.4) 118 (45.2) 0.034
4001-10000 65 (49.6) 120 (46.0)
≤ 4000 21 (16.0) 23 (8.8)
Gestational diabetes 16 (12.4) 05 (1.9) < 0.001
Urinary tract infection 39 (31.0) 47 (18.5) 0.006
Pregestational Diabetes 
Mellitus
07 (5.6) 02 (0.8) 0.004
Family History of DM 56 (43.8) 75 (29.6) 0.006
Family History of 
Hypertension
76 (58.9) 100 (38.5) < 0.001
Perceived Stress Score* 22 ± 6.1 20 ± 6.2 0.002
Husband's Age* 33.5 ± 12.9 33.5 ± 13.5 0.981Shamsi et al. BMC Women's Health 2010, 10:14
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family history of chronic hypertension on preeclampsia
risk.
Women's family history of chronic hypertension is an
important and easy to acquire clinical risk marker of
preeclampsia compared to the biochemical markers.
During the past 100 years numerous clinical, biophysical,
and biochemical tests have been suggested to identify
women who are at increased risk for future development
of preeclampsia. Unfortunately, these biomarkers have
limited sensitivity and are expensive enough for our
women to be clinically useful for the prediction of preec-
lampsia in our setting. The family history of hypertension
questions can be used as an inexpensive and feasible
screening tool to identify pregnant women in a develop-
ing country like Pakistan to monitor the signs of preec-
lampsia during early pregnancy.
Our study showed an association of mental stress dur-
ing pregnancy and development of preeclampsia. Depres-
sion and anxiety in early pregnancy are associated with
risk for preeclampsia, a risk further increased if associ-
ated with vaginosis [28] Stressful work environment and
stressful home environment are also associated with
preeclampsia [29]. The prenatal stress alters maternal
physiology and immune function in a manner consistent
with increased risk of pregnancy complications such as
preeclampsia and premature labor [30]. In another study
work-related psychosocial strain increased the risk of PE
[31]. Vasoconstriction in preeclampsia may develop early
in pregnancy. Indeed, increased uterine artery resistance
in maternal anxiety could be a primary manifestation or
even the cause of preeclampsia [32,33].
Several limitations must be considered when interpret-
ing the results from our study. First of all recall bias and
inability to establish temporality between preeclampsia
and certain variables are inherent due to the case control
study design. We cannot exclude the possibility that our
results could be partially confounded by unidentified risk
factors. Our study would have been strengthened by a
larger number of preeclamptic women, particularly those
with histories of exposures like extremes of age, condom
use, women with change in paternity. Prepregnancy
weights and body mass index (BMI) were assessed by
subtracting the average weight gain from the full term
maternal weight which might not be a good proxy mea-
sure. There is certainly underreporting of smoking, con-
dom use and therefore we could not establish a
relationship between them and preeclampsia risk.
Dietary and other lifestyle changes relationship with
preeclampsia not analyzed in this study. This being a hos-
pital based study; the results may not be applicable to the
general population at large. We could not establish a rela-
tionship between certain factors like condom use and
Condom use around the 
time of conception
17 (13.5) 34 (13.7) 0.954
Height* (centimeters) 150.8 ± 22.3 149.5 ± 23.5 0.592
Weight*(kilograms) 57.3 ± 15.8 55.0 ± 12.2 0.002
BMI‡
<18.5 18 (13.7) 37 (14.1) 0.502
18.5-24.9 78 (59.5) 171 (65.3)
25-29.9 23 (17.6) 39 (14.9)
≥ 30 12 (9.2) 15 (5.7)
Gestational age* (weeks) 36.2 ± 2.2 37.0 ± 1.2 <0.001
Blood Group
A+/A- 30 (24) 47 (18.4) 0.326
B+/B- 42 (33.6) 75 (29.4)
AB+/AB- 11 (8.8) 30 (11.8)
O+/O- 42 (33.6) 103 (40.4)
Rh Factor positive 120 (96) 231 (90.6) 0.067
Rh factor negative 5 (4) 24 (9.4)
Sex of Baby
Male 77 (61.1) 151 (58.5) 0.628
Female 49 (38.9) 107 (41.5)
*Plus-minus values are means ± SD.
‡BMI = body mass index, calculated by dividing weight in kilograms with height in meters squared.
Table 1: Table showing demographic, socio-economic and obstetrical characteristics of cases and controls with 
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change of paternity because of their low prevalence of
these exposures in our population. The risk factors of
preeclampsia may be different in early vs. late onset of
preeclampsia but we did not record the gestational age of
PE diagnosis and therefore we were unable to categorize
PE in early vs. late onset.
The study was conducted in accordance with the Amer-
ican College of Obstetricians & Gynecologists (ACOG)
criteria and ICD 9& 10 for preeclampsia. The American
College of Obstetricians & Gynecologists (ACOG) defini-
tion for preeclampsia was used to avoid misclassification
of preeclampsia with gestational hypertension as well as
superimposed preeclampsia [34]. The participation rate
for both control and cases subjects was 100%, so there
was no selection bias. The data collected was mainly by
classified doctors in gynecological and Obstetrics
Departments with rich clinical as well as research experi-
ence and therefore, the quality of data collected was good
and accurate.
Some of the predictors like Diabetes and GDM are
modifiable and preventable and others like family history
of preeclampsia even if not amenable to change but still
are useful in identifica tion of women at high risk who
require extra vigilance. If greater awareness of the associ-
ated risk factors leads to earlier diagnosis and improved
management, there may be scope for reducing a propor-
tion of the morbidity and mortality from preeclampsia.
Conclusion
Factors like gestational diabetes, pregestational diabetes,
family history of hypertension and mental stress during
pregnancy can be used as screening tools for preeclamp-
sia prediction. These factors can help identify pregnant
women who need closer monitoring for the signs of
preeclampsia during early pregnancy. Every woman dur-
ing the antenatal visit should also be asked for the family
history hypertension in order to better estimate the pos-
sible risk of developing preeclampsia. These risk factors
Table 2: Table based on multivariable analysis showing the association of independent variables with PE risk among 
women in maternity hospitals of Karachi and Rawalpindi (January 2006-December 2007)
Variables Matched unadjusted OR(95% CI) Matched adjusted OR(95%CI)
Gestational diabetes 6.40 (2.34, 17.4) 6.57 (1.94, 22.25)
Urinary tract infection 2.0 (1.21, 3.49) NS
Pregestational Diabetes Mellitus 6.56 (1.36, 31.7) 7.36 (1.37, 33.66)
Family History of DM 1.88 (1.18, 3.00) NS
Family History of Hypertension 2.24 (1.45, 3.46) 2.06 (1.27, 3.35)
Perceived Stress Score*
(for every 5 unit change)
1.33 (1.21, 1.46) 1.32 (1.19, 1.46)
Husband's Age* 1.0 (0.98, 1.02) NS
Condom use around the time of 
conception
1.02 (0.50, 2.11) NS
Height* (centimeters) 1.01 (.98, 1.05) NS
Weight*(kilograms) 1.02 (1.01, 1.04) NS
BMI 1.05 (1.00, 1.11) NS
Sex of Baby
Male
Female
1.15 (0.74, 1.78)1 NS
Monthly Household Income
> 10000 0.35 (0.16 " 0.76) NS
4001 " 10000 0.54 (0.26 " 1.13) NS
< 4000 1
* Plus-minus values are means ± SD.
NS Nonsignificant
Multivariate adjusted model was adjusted for maternal age, socioeconomic status measured by ownership of house, number of household 
members and monthly household income, urine tract infection during pregnancy, family history of diabetes mellitus,
maternal weight, Rh factor.Shamsi et al. BMC Women's Health 2010, 10:14
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should be considered for the designs of future studies of
preeclampsia in our population of Pakistani women.
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